Analysts Expect 10% Gains Ahead For The Holdings of DIVB
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 22 2025
0mins
Source: NASDAQ.COM
ETF Analyst Target Price Insights: The iShares Core Dividend ETF (DIVB) has an implied analyst target price of $53.27, indicating a potential upside of 10.47% from its current trading price of $48.22. Notable underlying holdings with significant upside include DENTSPLY SIRONA Inc, Victory Capital Holdings Inc, and Cohen & Steers Inc.
Market Sentiment and Analyst Justifications: There are questions regarding whether analysts' target prices are justified or overly optimistic, as high targets may reflect future optimism but could also lead to downgrades if they do not align with recent market developments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy XRAY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on XRAY
Wall Street analysts forecast XRAY stock price to rise
16 Analyst Rating
2 Buy
13 Hold
1 Sell
Hold
Current: 10.090
Low
12.00
Averages
13.04
High
17.00
Current: 10.090
Low
12.00
Averages
13.04
High
17.00
About XRAY
DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Dentsply Sirona Appoints New CFO
- Executive Change: Dentsply Sirona announced the appointment of John Fortson as Chief Financial Officer and Executive Vice President, effective July 20, 2025, following the departure of the previous CFO, indicating the company's efforts to stabilize its executive leadership.
- Leadership Experience: Fortson brings over 25 years of leadership experience in finance, operations, and strategy across public and private equity-backed companies, having most recently served as President and CFO of Kymera International, suggesting that his extensive background may provide new perspectives and strategic direction for Dentsply.
- Market Reaction: On the day prior to the announcement, Dentsply's shares closed at $10.14 on Nasdaq, down 4.11%, reflecting a cautious market sentiment regarding the executive change, which could impact investor confidence.
- Interim Leadership: Prior to Fortson's appointment, the company was under the interim leadership of Leslie Varon, highlighting the urgency and significance of the new CFO's role in guiding financial decisions and strategic execution during this transitional period.
See More
Dentsply Sirona Appoints New CFO
- Executive Appointment: Dentsply Sirona announced the appointment of John Fortson as CFO effective July 20, bringing 13 years of experience as CFO or CEO in global manufacturing, which is expected to enhance the company's financial management capabilities.
- Previous Experience: Before joining Dentsply, Fortson served as CFO at Kymera International and held various executive roles at Ingevity, including CFO, President, and board member, showcasing his extensive background in financial and operational management.
- Financial Targets: Dentsply projects 2026 sales between $3.5 billion and $3.6 billion, with an EPS target of $1.40 to $1.50, indicating a positive outlook for future growth while aiming for approximately $120 million in annual savings through operational optimization.
- Market Reaction: This appointment may bolster investor confidence in Dentsply, particularly as the company is undergoing strategic adjustments to meet its financial goals, with Fortson's addition seen as a crucial step towards enhancing the company's financial health.
See More
Dentsply Sirona Appoints New CFO John Fortson to Drive Growth Strategy
- Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which will enhance the company's strategic perspective and capital markets expertise.
- Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, significantly improving operational efficiency and financial discipline within the organization.
- Strategic Growth Plan: CEO Dan Scavilla highlighted that Fortson's leadership style and strategic mindset will be instrumental in advancing the company's Return-to-Growth Action Plan, aimed at achieving long-term growth and shareholder value creation.
- Financial Transformation Background: During his tenure at Ingevity Corporation, Fortson implemented a $700 million credit facility and a $300 million high-yield bond offering, strengthening the company's capital structure and demonstrating his capability in financial transformation.
See More
Investigation into Dentsply Sirona Shareholder Rights
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers and directors of Dentsply Sirona Inc. breached their fiduciary duties, which could impact corporate governance and shareholder rights.
- Legal Fee Arrangement: The firm operates on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal fees, thereby reducing financial barriers to participation and encouraging more shareholders to assert their rights.
- Importance of Participation: Shareholder involvement can drive improvements in company policies, practices, and oversight mechanisms, enhancing transparency and accountability, which ultimately contributes to increased shareholder value and long-term company growth.
- Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, showcasing their expertise in protecting investor rights.
See More
Dentsply Sirona Expands U.S. Distribution Network
- Strengthened Partnership: Dentsply Sirona's partnership with Nashville Dental, Inc. will take effect on August 1, 2026, allowing NDI to distribute the full range of Dentsply Sirona's digital technology solutions across nine states, enhancing the company's market penetration in the Southeast and Mid-Atlantic regions.
- Promotion of Digital Technologies: The collaboration with NDI will introduce Dentsply Sirona's CEREC system, Primescan intraoral scanners, and digital imaging solutions to more dental practices, addressing the growing demand for digital dentistry and driving the adoption of digitally connected workflows.
- Localized Service Advantage: NDI, as a well-established full-service organization, provides support in equipment technology, installation, service, and practice advisory, ensuring that customers receive localized service and support when utilizing Dentsply Sirona's digital solutions, thereby enhancing customer satisfaction.
- Market Strategy Optimization: This agreement underscores Dentsply Sirona's strategic focus in the U.S. market, aiming to enhance market accessibility through a balanced mix of direct and indirect channels, promoting the adoption of digital dental solutions and supporting the company's long-term growth objectives.
See More
DENTSPLY SIRONA Launches AI Dental Imaging Tool Smart View, Detect
- FDA Approval of New Product: DENTSPLY SIRONA launched Smart View, Detect, the first FDA-cleared AI-powered CBCT diagnostic aid, marking a significant innovation in digital dentistry, despite a 28.5% decline in its stock price over the past year.
- Sales and Income Challenges: First-quarter 2026 sales were $880 million, roughly flat year-over-year, but the company swung from a net income of $20 million to a net loss of $10 million, indicating fragile profitability while maintaining full-year sales guidance of $3.5 billion to $3.6 billion.
- Expanded Distribution Agreement: DENTSPLY SIRONA expanded its U.S. distribution agreement with Atlanta Dental Supply, aiming to enhance market access for its digital dentistry solutions, although facing pressure from larger competitors.
- Advancement of Digital Strategy: The launch of Smart View, Detect integrated with the DS Core platform aims to drive growth in digital platforms and software subscription revenues, yet the conversion from product launches to sustained revenue growth remains a challenge.
See More
Dentsply Sirona Appoints New CFO
- Executive Change: Dentsply Sirona announced the appointment of John Fortson as Chief Financial Officer and Executive Vice President, effective July 20, 2025, following the departure of the previous CFO, indicating the company's efforts to stabilize its executive leadership.
- Leadership Experience: Fortson brings over 25 years of leadership experience in finance, operations, and strategy across public and private equity-backed companies, having most recently served as President and CFO of Kymera International, suggesting that his extensive background may provide new perspectives and strategic direction for Dentsply.
- Market Reaction: On the day prior to the announcement, Dentsply's shares closed at $10.14 on Nasdaq, down 4.11%, reflecting a cautious market sentiment regarding the executive change, which could impact investor confidence.
- Interim Leadership: Prior to Fortson's appointment, the company was under the interim leadership of Leslie Varon, highlighting the urgency and significance of the new CFO's role in guiding financial decisions and strategic execution during this transitional period.
See More
Dentsply Sirona Appoints New CFO
- Executive Appointment: Dentsply Sirona announced the appointment of John Fortson as CFO effective July 20, bringing 13 years of experience as CFO or CEO in global manufacturing, which is expected to enhance the company's financial management capabilities.
- Previous Experience: Before joining Dentsply, Fortson served as CFO at Kymera International and held various executive roles at Ingevity, including CFO, President, and board member, showcasing his extensive background in financial and operational management.
- Financial Targets: Dentsply projects 2026 sales between $3.5 billion and $3.6 billion, with an EPS target of $1.40 to $1.50, indicating a positive outlook for future growth while aiming for approximately $120 million in annual savings through operational optimization.
- Market Reaction: This appointment may bolster investor confidence in Dentsply, particularly as the company is undergoing strategic adjustments to meet its financial goals, with Fortson's addition seen as a crucial step towards enhancing the company's financial health.
See More
Dentsply Sirona Appoints New CFO John Fortson to Drive Growth Strategy
- Executive Appointment: Dentsply Sirona has appointed John Fortson as Chief Financial Officer, effective July 20, bringing over 25 years of leadership experience in finance and operations, which will enhance the company's strategic perspective and capital markets expertise.
- Extensive Industry Experience: While serving as CFO at Kymera International, Fortson successfully integrated 21 manufacturing facilities and consolidated 12 ERP systems, significantly improving operational efficiency and financial discipline within the organization.
- Strategic Growth Plan: CEO Dan Scavilla highlighted that Fortson's leadership style and strategic mindset will be instrumental in advancing the company's Return-to-Growth Action Plan, aimed at achieving long-term growth and shareholder value creation.
- Financial Transformation Background: During his tenure at Ingevity Corporation, Fortson implemented a $700 million credit facility and a $300 million high-yield bond offering, strengthening the company's capital structure and demonstrating his capability in financial transformation.
See More
Investigation into Dentsply Sirona Shareholder Rights
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating whether certain officers and directors of Dentsply Sirona Inc. breached their fiduciary duties, which could impact corporate governance and shareholder rights.
- Legal Fee Arrangement: The firm operates on a contingent fee basis, meaning shareholders will not incur out-of-pocket legal fees, thereby reducing financial barriers to participation and encouraging more shareholders to assert their rights.
- Importance of Participation: Shareholder involvement can drive improvements in company policies, practices, and oversight mechanisms, enhancing transparency and accountability, which ultimately contributes to increased shareholder value and long-term company growth.
- Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, showcasing their expertise in protecting investor rights.
See More
Dentsply Sirona Expands U.S. Distribution Network
- Strengthened Partnership: Dentsply Sirona's partnership with Nashville Dental, Inc. will take effect on August 1, 2026, allowing NDI to distribute the full range of Dentsply Sirona's digital technology solutions across nine states, enhancing the company's market penetration in the Southeast and Mid-Atlantic regions.
- Promotion of Digital Technologies: The collaboration with NDI will introduce Dentsply Sirona's CEREC system, Primescan intraoral scanners, and digital imaging solutions to more dental practices, addressing the growing demand for digital dentistry and driving the adoption of digitally connected workflows.
- Localized Service Advantage: NDI, as a well-established full-service organization, provides support in equipment technology, installation, service, and practice advisory, ensuring that customers receive localized service and support when utilizing Dentsply Sirona's digital solutions, thereby enhancing customer satisfaction.
- Market Strategy Optimization: This agreement underscores Dentsply Sirona's strategic focus in the U.S. market, aiming to enhance market accessibility through a balanced mix of direct and indirect channels, promoting the adoption of digital dental solutions and supporting the company's long-term growth objectives.
See More
DENTSPLY SIRONA Launches AI Dental Imaging Tool Smart View, Detect
- FDA Approval of New Product: DENTSPLY SIRONA launched Smart View, Detect, the first FDA-cleared AI-powered CBCT diagnostic aid, marking a significant innovation in digital dentistry, despite a 28.5% decline in its stock price over the past year.
- Sales and Income Challenges: First-quarter 2026 sales were $880 million, roughly flat year-over-year, but the company swung from a net income of $20 million to a net loss of $10 million, indicating fragile profitability while maintaining full-year sales guidance of $3.5 billion to $3.6 billion.
- Expanded Distribution Agreement: DENTSPLY SIRONA expanded its U.S. distribution agreement with Atlanta Dental Supply, aiming to enhance market access for its digital dentistry solutions, although facing pressure from larger competitors.
- Advancement of Digital Strategy: The launch of Smart View, Detect integrated with the DS Core platform aims to drive growth in digital platforms and software subscription revenues, yet the conversion from product launches to sustained revenue growth remains a challenge.
See More
